These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5485075)

  • 1. [Treatments of the sympathic factor of hyperthyroidism].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():60-8. PubMed ID: 5485075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of the adrenergic receptors. II. Use of their inhibitors in endocrinology; indications and results].
    Mornex R
    Ann Endocrinol (Paris); 1967; 28(4):557-73. PubMed ID: 6081825
    [No Abstract]   [Full Text] [Related]  

  • 3. [The place of new sympatholytics in treatment of hyperthyroidism and hypothyroidism].
    Bricaire H; Joly J
    Therapeutique; 1969 Jan; 45(1):61-2. PubMed ID: 5792154
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyrotoxicosis presenting as choreoathetosis.
    Heffron W; Eaton RP
    Ann Intern Med; 1970 Sep; 73(3):425-8. PubMed ID: 4195476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guanethidine in the control of the hypersympathetic syndrome associated with thyrotoxicosis].
    Bianchini E; Tentoni M
    Boll Soc Med Chir Cremona; 1966; 20(1):59-64. PubMed ID: 5947327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effect of sympatholytic, adrenergic beta receptor blockaders and strumigens in hyperthyroidism].
    Soumar J; Bednár J; Strasek J
    Cas Lek Cesk; 1972 Dec; 111(51):1205-19. PubMed ID: 4565822
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic nervous system blocking in hyperthyroidism.
    Vinik AI; Pimstone BL; Hoffenberg R
    J Clin Endocrinol Metab; 1968 May; 28(5):725-7. PubMed ID: 4172456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of thyrotoxic crises].
    Erikssen J
    Tidsskr Nor Laegeforen; 1971 Oct; 91(28):2018-9. PubMed ID: 5130370
    [No Abstract]   [Full Text] [Related]  

  • 9. New tactics for hyperthyroidism: sympathetic blockade.
    Riddle M; Schwartz TB
    Ann Intern Med; 1970 May; 72(5):749-51. PubMed ID: 4393597
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathetic blockade in hyperthyroidism. Preoperative management following toxic reaction to antithyroid drugs.
    Becker FO; Schwartz TB
    Arch Intern Med; 1972 Jun; 129(6):967-71. PubMed ID: 4113493
    [No Abstract]   [Full Text] [Related]  

  • 11. Choreoathetosis in hyperthyroidism: a manifestation of a hyperadrenergic state.
    Heffron WA; Appenzeller O
    Trans Am Neurol Assoc; 1970; 95():187-91. PubMed ID: 5514364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of the treatment of hyperthyroidism with guanethidine].
    Goldszmidt M; Garmendia F; Pereda S
    Rev Soc Peru Endocrinol; 1965 Sep; 2(2):212-4. PubMed ID: 5860054
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with guanethidine in the treatment of hyperthyroidism].
    Laubinger G
    Med Welt; 1967 May; 21():1316-9. PubMed ID: 5612543
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional intravascular sympathetic (RIS) block with guanethidine.
    Aarts HF; Hulsebosch HJ
    Neth J Surg; 1980; 32(3):108-12. PubMed ID: 7422136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the urinary excretion of VMA (vanilmandelic acid) in patients with hyperthyroidism treated chronically with guanethidine].
    Portioli I; Bufano G; Rocchi F; Tagliavini S; Botti G
    Clin Ter; 1969 Apr; 49(2):119-33. PubMed ID: 5407313
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of dihydroergotamine in certain diseases or syndromes characterized by hypertonus of the sympathetic nervous system].
    Vancini B
    Clin Ter; 1967 Apr; 41(1):55-71. PubMed ID: 5614300
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the effect of the sympathic beta-receptor blocking agent propranolol on heart rate in hyperthyroidism].
    Tragl KH; Klotz HG; Geyer G
    Wien Klin Wochenschr; 1967 May; 79(18):352-4. PubMed ID: 5585993
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of guanethidine eye drops in dysthyroid lid retraction.
    Martin B; Jay B
    Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of reserpine and guanethidine in the continuous treatment of hyperthyroidism].
    Bekaert J; Elewaut A
    Acta Clin Belg; 1967; 22(2):85-90. PubMed ID: 4169517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.